Anemia and Mortality in Heart Failure Patients. A Systematic Review and Meta-Analysis

Journal of the American College of Cardiology

Volumn 52, Issue 10, 2008, Pages 818-827

  Groenveld, Hessel F ^a   Januzzi, James L ^b   Damman, Kevin ^a   van Wijngaarden, Jan ^c   Hillege, Hans L ^a   van Veldhuisen, Dirk J ^a   van der Meer, Peter ^b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c DEVENTER HOSPITAL   (Netherlands)

Author keywords

anemia; heart failure; prognosis

Indexed keywords

HEMOGLOBIN;

ANEMIA; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; DIASTOLIC HEART FAILURE; FOLLOW UP; HEART FAILURE; HEMOGLOBIN BLOOD LEVEL; HIGH RISK PATIENT; HUMAN; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; SYSTEMATIC REVIEW; SYSTOLIC HEART FAILURE;

ADULT; AGED; AGED, 80 AND OVER; ANEMIA; CHRONIC DISEASE; CONFIDENCE INTERVALS; FEMALE; HEART FAILURE; HEART FAILURE, DIASTOLIC; HEART FAILURE, SYSTOLIC; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS;

EID: 49849088979     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.04.061     Document Type: Article

References (60)

1. Anand I., McMurray J.J., Whitmore J., et al. Anemia and its relationship to clinical outcome in heart failure. Circulation 110 (2004) 149-154
2. Ezekowitz J.A., McAlister F.A., and Armstrong P.W. Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure. Circulation 107 (2003) 223-225
3. Go A.S., Yang J., Ackerson L.M., et al. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) study. Circulation 113 (2006) 2713-2723
4. Kosiborod M., Curtis J.P., Wang Y., et al. Anemia and outcomes in patients with heart failure: a study from the National Heart Care Project. Arch Intern Med 165 (2005) 2237-2244
5. Maggioni A.P., Opasich C., Anand I., et al. Anemia in patients with heart failure: prevalence and prognostic role in a controlled trial and in clinical practice. J Card Fail 11 (2005) 91-98
6. Varadarajan P., Gandhi S., Sharma S., Umakanthan B., and Pai R.G. Prognostic significance of hemoglobin level in patients with congestive heart failure and normal ejection fraction. Clin Cardiol 29 (2006) 444-449
7. Berry C., Norrie J., Hogg K., Brett M., Stevenson K., and McMurray J.J. The prevalence, nature, and importance of hematologic abnormalities in heart failure. Am Heart J 151 (2006) 1313-1321
8. Elabbassi W., Fraser M., Williams K., Cassan D., and Haddad H. Prevalence and clinical implications of anemia in congestive heart failure patients followed at a specialized heart function clinic. Congest Heart Fail 12 (2006) 258-264
9. Horwich T.B., Fonarow G.C., Hamilton M.A., MacLellan W.R., and Borenstein J. Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol 39 (2002) 1780-1786
10. Komajda M., Anker S.D., Charlesworth A., et al. The impact of new onset anaemia on morbidity and mortality in chronic heart failure: results from COMET. Eur Heart J 27 (2006) 1440-1446
11. Maraldi C., Volpato S., Cesari M., et al. Anemia, physical disability, and survival in older patients with heart failure. J Card Fail 12 (2006) 533-539
12. Al-Ahmad A., Rand W.M., Manjunath G., et al. Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. J Am Coll Cardiol 38 (2001) 955-962
13. Felker G.M., Shaw L.K., Stough W.G., and O'Connor C.M. Anemia in patients with heart failure and preserved systolic function. Am Heart J 151 (2006) 457-462
14. Grigorian Shamagian L., Varela R.A., Garcia-Acuna J.M., Mazon R.P., Virgos L.A., and Gonzalez-Juanatey J.R. Anaemia is associated with higher mortality among patients with heart failure with preserved systolic function. Heart 92 (2006) 780-784
15. Newton J.D., and Squire I.B. Glucose and haemoglobin in the assessment of prognosis after first hospitalisation for heart failure. Heart 92 (2006) 1441-1446
16. Ralli S., Horwich T.B., and Fonarow G.C. Relationship between anemia, cardiac troponin I, and B-type natriuretic peptide levels and mortality in patients with advanced heart failure. Am Heart J 150 (2005) 1220-1227
17. Schou M., Gustafsson F., Kistorp C.N., Corell P., Kjaer A., and Hildebrandt P.R. Prognostic usefulness of anemia and N-terminal pro-brain natriuretic peptide in outpatients with systolic heart failure. Am J Cardiol 100 (2007) 1571-1576
18. Formiga F., Chivite D., Castaner O., Manito N., Ramon J.M., and Pujol R. Anemia in new-onset congestive heart failure inpatients admitted for acute decompensation. Eur J Intern Med 17 (2006) 179-184
19. Gardner R.S., Chong K.S., Morton J.J., and McDonagh T.A. N-terminal brain natriuretic peptide, but not anemia, is a powerful predictor of mortality in advanced heart failure. J Card Fail 11 (2005) S47-S53
20. Silva R.P., Barbosa P.H., Kimura O.S., et al. Prevalance of anemia and its association with cardio-renal syndrome. Int J Cardiol 120 (2007) 232-236
21. van der Meer P., Voors A.A., Lipsic E., van Gilst W.H., and van Veldhuisen D.J. Erythropoietin in cardiovascular diseases. Eur Heart J 25 (2004) 285-291
22. van Veldhuisen D.J., and McMurray J.J. Are erythropoietin stimulating proteins safe and efficacious in heart failure? Why we need an adequately powered randomised outcome trial. Eur J Heart Fail 9 (2007) 110-112
23. Stroup D.F., Berlin J.A., Morton S.C., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283 (2000) 2008-2012
24. Ezekowitz J.A., McAlister F.A., and Armstrong P.W. The interaction among sex, hemoglobin and outcomes in a specialty heart failure clinic. Can J Cardiol 21 (2005) 165-171
25. Hebert K., Horswell R., Arcement L., Hare J., and Stevenson L. The effect of anemia on mortality in indigent patients with mild-to-moderate chronic heart failure. Congest Heart Fail 12 (2006) 75-79
26. Kalra P.R., Collier T., Cowie M.R., et al. Haemoglobin concentration and prognosis in new cases of heart failure. Lancet 362 (2003) 211-212
27. Harris R.P., Helfand M., Woolf S.H., et al. Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med 20 (2001) 21-35
28. Altman D.G. Systematic reviews of evaluations of prognostic variables. BMJ 323 (2001) 224-228
29. Anand I.S., Kuskowski M.A., Rector T.S., et al. Anemia and change in hemoglobin over time related to mortality and morbidity in patients with chronic heart failure: results from Val-HeFT. Circulation 112 (2005) 1121-1127
30. van der Meer P., Voors A.A., Lipsic E., Smilde T.D., van Gilst W.H., and van Veldhuisen D.J. Prognostic value of plasma erythropoietin on mortality in patients with chronic heart failure. J Am Coll Cardiol 44 (2004) 63-67
31. Terrovitis J.V., Anastasiou-Nana M.I., Alexopoulos G.P., et al. Prevalence and prognostic significance of anemia in patients with congestive heart failure treated with standard vs high doses of enalapril. J Heart Lung Transplant 25 (2006) 333-338
32. Tanner H., Moschovitis G., Kuster G.M., et al. The prevalence of anemia in chronic heart failure. Int J Cardiol 86 (2002) 115-121
33. Szachniewicz J., Petruk-Kowalczyk J., Majda J., et al. Anaemia is an independent predictor of poor outcome in patients with chronic heart failure. Int J Cardiol 90 (2003) 303-308
34. Sharma R., Francis D.P., Pitt B., Poole-Wilson P.A., Coats A.J., and Anker S.D. Haemoglobin predicts survival in patients with chronic heart failure: a substudy of the ELITE II trial. Eur Heart J 25 (2004) 1021-1028
35. Rosolova H., Cech J., Simon J., et al. Short to long term mortality of patients hospitalised with heart failure in the Czech Republic-a report from the EuroHeart Failure Survey. Eur J Heart Fail 7 (2005) 780-783
36. O'Meara E., Clayton T., McEntegart M.B., et al. Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. Circulation 113 (2006) 986-994
37. Mozaffarian D., Nye R., and Levy W.C. Anemia predicts mortality in severe heart failure: the prospective randomized amlodipine survival evaluation (PRAISE). J Am Coll Cardiol 41 (2003) 1933-1939
38. McClellan W.M., Flanders W.D., Langston R.D., Jurkovitz C., and Presley R. Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: a population-based study. J Am Soc Nephrol 13 (2002) 1928-1936
39. Kosiborod M., Smith G.L., Radford M.J., Foody J.M., and Krumholz H.M. The prognostic importance of anemia in patients with heart failure. Am J Med 114 (2003) 112-119
40. Kerzner R., Gage B.F., Freedland K.E., and Rich M.W. Predictors of mortality in younger and older patients with heart failure and preserved or reduced left ventricular ejection fraction. Am Heart J 146 (2003) 286-290
41. de Silva R., Rigby A.S., Witte K.K., et al. Anemia, renal dysfunction, and their interaction in patients with chronic heart failure. Am J Cardiol 98 (2006) 391-398
42. Akhter M.W., Aronson D., Bitar F., et al. Effect of elevated admission serum creatinine and its worsening on outcome in hospitalized patients with decompensated heart failure. Am J Cardiol 94 (2004) 957-960
43. Varat M.A., Adolph R.J., and Fowler N.O. Cardiovascular effects of anemia. Am Heart J 83 (1972) 415-426
44. Dries D.L., Exner D.V., Domanski M.J., Greenberg B., and Stevenson L.W. The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. J Am Coll Cardiol 35 (2000) 681-689
45. Foley R.N. Myocardial disease, anemia, and erythrocyte-stimulating proteins in chronic kidney disease. Rev Cardiovasc Med 6 Suppl 3 (2005) S27-S34
46. Ruilope L.M., van Veldhuisen D.J., Ritz E., and Luscher T.F. Renal function: the Cinderella of cardiovascular risk profile. J Am Coll Cardiol 38 (2001) 1782-1787
47. Smith G.L., Lichtman J.H., Bracken M.B., et al. Renal impairment and outcomes in heart failure: systematic review and meta-analysis. J Am Coll Cardiol 47 (2006) 1987-1996
48. Silverberg D.S., Wexler D., and Iaina A. The importance of anemia and its correction in the management of severe congestive heart failure. Eur J Heart Fail 4 (2002) 681-686
49. Silverberg D.S., Wexler D., Sheps D., et al. The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study. J Am Coll Cardiol 37 (2001) 1775-1780
50. Palazzuoli A., Silverberg D., Iovine F., et al. Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia. Am Heart J 152 (2006) 1096-1115
51. van Veldhuisen D.J., Dickstein K., Cohen-Solal A., et al. Randomized, double-blind, placebo-controlled study to evaluate the effect of two dosing regimens of darbepoetin alfa in patients with heart failure and anaemia. Eur Heart J 28 (2007) 2208-2216
52. Ghali J.K., Anand I.S., Abraham W.T., et al. Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia. Circulation 117 (2008) 526-535
53. Bennett C.L., Silver S.M., Djulbegovic B., et al. Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia. JAMA 299 (2008) 914-924
54. Drueke T.B., Locatelli F., Clyne N., et al. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 355 (2006) 2071-2084
55. Singh A.K., Szczech L., Tang K.L., et al. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 355 (2006) 2085-2098
56. Young J.B., Anand I.S., Diaz R., et al. Reduction of events with darbepoetin alfa in Heart Failure (RED-HF) trial. (abstr). J Card Fail 12 Suppl 1 (2006) S77
57. Okonko D.O., Grzeslo A., Witkowski T., et al. Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial. J Am Coll Cardiol 51 (2008) 103-112
58. Toblli J.E., Lombrana A., Duarte P., and Di G.F. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency. J Am Coll Cardiol 50 (2007) 1657-1665
59. Flather M.D., Farkouh M.E., Pogue J.M., and Yusuf S. Strengths and limitations of meta-analysis: larger studies may be more reliable. Control Clin Trials 18 (1997) 568-579
60. Tang W.H., Tong W., Jain A., Francis G.S., Harris C.M., and Young J.B. Evaluation and long-term prognosis of new-onset, transient, and persistent anemia in ambulatory patients with chronic heart failure. J Am Coll Cardiol 51 (2008) 569-576